Shun Lu

563 total citations
15 papers, 229 citations indexed

About

Shun Lu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Shun Lu has authored 15 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Shun Lu's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Research Studies (4 papers). Shun Lu is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Research Studies (4 papers). Shun Lu collaborates with scholars based in China, United States and Germany. Shun Lu's co-authors include Kai Schledzewski, Cyrill Géraud, Sergij Goerdt, Astrid Schmieder, Diana Klein, Alexandra Demory, Carsten Sticht, Carolin Mogler, Günter J. Hämmerling and Thomas Longerich and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Annals of Oncology.

In The Last Decade

Shun Lu

12 papers receiving 226 citations

Peers

Shun Lu

HEPAT

ONCOL

EPIDE

PRM

Zhiyu Li China

Hiroki Teraoku Japan

Shuji Uematsu Japan

Maria Aurelia Barbera Italy

Zhili Wen China

Zhang Cheng China

Mengxian Tu China

Liye Tao China

Vanessa Rüsseler Germany

Yibo Cai China

Zhiyu Li China

Shun Lu

75 ×0.8

HEPAT

73 ×0.9

110 ×1.5

ONCOL

89 ×1.4

EPIDE

35 ×0.7

PRM

Citations per year, relative to Shun Lu Shun Lu (= 1×) peers Zhiyu Li

Countries citing papers authored by Shun Lu

Since Specialization

Citations

This map shows the geographic impact of Shun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shun Lu more than expected).

Fields of papers citing papers by Shun Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shun Lu. The network helps show where Shun Lu may publish in the future.

Co-authorship network of co-authors of Shun Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shun Lu. A scholar is included among the top collaborators of Shun Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shun Lu. Shun Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mathias, Clarissa, Yasushi Goto, Shun Lu, et al.. (2025). ARTEMIDE-Lung03: A phase 3, randomized, double-blind, multicenter, global study of rilvegostomig or pembrolizumab in combination with platinum-based chemotherapy as first-line treatment for patients with metastatic non-squamous non-small-cell lung cancer whose tumors express PD-L1.. Journal of Clinical Oncology. 43(16_suppl).

Yu, Yongfeng, et al.. (2025). Dacomitinib in the treatment of EGFR-mutated non-small cell lung cancer with brain metastases: an open-label, multicenter, phase II study. Lung Cancer. 207. 108710–108710.

Lu, Shun, et al.. (2024). Quantitative Measurement of Temperature-Dependent Quasiparticle Scattering of the Topological Surface States in Bi₂Se₃. Chinese Physics Letters. 42(1). 17303–17303. 1 indexed citations

Lu, Shun, Cheng‐Ta Yang, Yong‐Seok Song, et al.. (2021). 1208P Final results of APOLLO study: Overall survival (OS) of aumolertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). Annals of Oncology. 32. S962–S962. 6 indexed citations

Jiang, Long, et al.. (2020). Immuno-based therapeutic strategies for initial unresectable locally advanced non-small cell lung cancer: a case report. Translational Lung Cancer Research. 9(3). 803–806. 2 indexed citations

Lu, Shun, Yongfeng Yu, & Wenxiang Ji. (2016). Guidelines for lung cancer in 2015: Consensus and controversy. Jiefangjun yixue zazhi. 41(1). 1–6. 1 indexed citations

Hong, Jian, Yongfeng Yu, Lan Shen, & Shun Lu. (2015). Oral 1.03. Frequent PD-L1 expression in thymic squamous cell carcinoma of Chinese patients. Journal of Thoracic Disease. 7(3).

Lu, Shun, et al.. (2015). Detection and correlation analysis of serum cytokines in non-small-cell lung cancer patients with bone and non-bone metastases. Patient Preference and Adherence. 9. 1165–1165. 7 indexed citations

Lu, Shun, Li Lü, Yi Luo, et al.. (2015). A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer. Journal of Thoracic Oncology. 10(1). 206–211. 40 indexed citations

10.

Zhang, Li, Shun Lu, Ying Cheng, et al.. (2013). Different-dose docetaxel plus cisplatin as first-line chemotherapy and then maintenance therapy with single-agent docetaxel for advanced non-small cell lung cancer (TFINE study, C-TONG 0904).. Journal of Clinical Oncology. 31(15_suppl). 8015–8015. 6 indexed citations

11.

Géraud, Cyrill, Carolin Mogler, Anja Runge, et al.. (2013). Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin‐2 expression in peri‐tumourous liver correlates with increased survival. Liver International. 33(9). 1428–1440. 57 indexed citations

12.

Shen, Lan, Ziming Li, & Shun Lu. (2011). [Clinical significance of C-reactive protein in patients with stage I non-small cell lung cancer].. PubMed. 33(6). 442–6. 6 indexed citations

13.

Géraud, Cyrill, Kai Schledzewski, Alexandra Demory, et al.. (2010). Liver Sinusoidal Endothelium: A Microenvironment-Dependent Differentiation Program in Rat Including the Novel Junctional Protein Liver Endothelial Differentiation-Associated Protein-1. Hepatology. 52(1). 313–326. 92 indexed citations

14.

Yu, Yongfeng, Zhiwei Chen, Zhengbo Song, et al.. (2010). A Cost-Effectiveness Analysis of Docetaxel versus Pemetrexed in Second-Line Chemotherapy for Stage IIIb or IV Non-Small Cell Lung Cancer in China. Chemotherapy. 56(6). 472–477. 6 indexed citations

15.

Zhang, Yifei, Zhiwei Chen, & Shun Lu. (2009). Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancer.. PubMed. 122(20). 2472–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact